Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 280-285 , December 2008

The Neuroprotection of Kappa Opioid Receptor Agonist BRL52537 is Partly Through Enhancing Endogenous GABA Function

  • Tsung-Ying Chen

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • Graduate Institute of Clinical Medicine, Department of Nursing, Tzu Chi University, Hualien, Taiwan
    • ,
  • Hsu-Tang Liu

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • ,
  • Chia-Ling Lee

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • ,
  • Jimmy Ong

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • ,
  • E-Jian Lee

      Affiliations

    • Neurophysiology Laboratory, National Cheng Kung University and Department of Surgery, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Ming-Hwang Shyr

      Affiliations

    • Department of Anesthesiology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Anesthesiology, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan

Received 20 November 2007 ,Revised 20 December 2007 ,Accepted 15 January 2008.

References 

  1. Baskin DS , Kuroda H , Hosobuchi Y , Lee NM . Treatment of stroke with opiate antagonists–effects of exogenous antagonists and dynorphin 1-13 . Neuropeptides . 1985;5:307–310
  2. Fried RL , Nowak TS . Opioid peptide levels in gerbil brain after transient ischemia: lasting depletion of hippocampal dynorphin . Stroke . 1987;18:765–770
  3. Hosobuchi Y , Baskin DS , Woo SK . Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone . Science . 1982;215:69–71
  4. Zabramski JM , Spetzler RF , Selman WR , et al.   Naloxone therapy during focal cerebral ischemia evaluation in a primate model . Stroke . 1984;15:621–627
  5. Baskin DS , Widmayer MA , Browning JL , et al.   Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats . Stroke . 1994;25:2047–2054
  6. Birch PJ , Rogers H , Hayes AG , et al.   Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist . Br J Pharmacol . 1991;103:1819–1823
  7. Mackay KB , Kusumoto K , Graham DI , McCulloch J . Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat . Brain Res . 1993;629:10–18
  8. Genovese RF , Moreton JE , Tortella FC . Evaluation of neuroprotection and behavioral recovery by the kappa-opioid, PD117302 following transient forebrain ischemia . Brain Res Bull . 1994;34:111–116
  9. Itoh J , Ukai M , Kameyama T . U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice . Brain Res . 1993;619:223–228
  10. Butcher SP , Bullock R , Graham DI , McCulloch J . Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion . Stroke . 1990;21:1727–1733
  11. Matsumoto K , Graf R , Rosner G , et al.   Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia . Brain Res . 1992;579:309–314
  12. Matsumoto K , Graf R , Rosner G , et al.   Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia . J Cereb Blood Flow Metab . 1993;13:586–594
  13. Takagi K , Ginsberg MD , Globus MY , et al.   Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology . J Cereb Blood Flow Metab . 1993;13:575–585
  14. Wahl F , Obrenovitch TP , Hardy AM , et al.   Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency . J Neurochem . 1994;63:1003–1011
  15. Obrenovitch TP , Urenjak J . Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? . J Neurotrauma . 1997;14:677–698
  16. Kanter ED , Kapur A , Haberly LB . A dendritic GABAA-mediated IPSP regulates facilitation of NMDA-mediated responses to burst stimulation of afferent fibers in piriform cortex . J Neurosci . 1996;16:307–312
  17. Cross AJ , Snape MF , Green AR . Chlormethiazole antagonises seizures induced by N-methyl-DL-aspartate without interacting with the NMDA receptor complex . Psychopharmacology (Berl) . 1993;112:403–406
  18. Ohkuma S , Chen SH , Katsura M , et al.   Muscimol prevents neuronal injury induced by NMDA . Jpn J Pharmacol . 1994;64:125–128
  19. Thoren P , Sjolander M . Chlormethiazole attenuates the derangement of sensory evoked potential (SEP) induced by ICV administration of NMDA . Psychopharmacology (Berl) . 1993;111:256–258
  20. Zhang Z , Chen TY , Kirsch JR , et al.   Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats . Anesth Analg . 2003;97:1776–1783
  21. Chen TY , Goyagi T , Toung TJ , et al.   Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats . Stroke . 2004;35:1180–1185
  22. Chen CH , Toung TJ , Hurn PD , et al.   Ischemic neuroprotection with selective kappa-opioid receptor agonist is gender specific . Stroke . 2005;36:1557–1561
  23. Schoffelmeer AN , Hogenboom F , Mulder AH . Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum . Br J Pharmacol . 1997;122:520–524
  24. Shippenberg TS , Chefer VI , Zapata A , Heidbreder CA . Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems . Ann N Y Acad Sci . 2001;937:50–73
  25. You ZB , Herrera-Marschitz M , Terenius L . Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides . J Pharmacol Exp Ther . 1999;290:1307–1315
  26. Goyagi T , Toung TJ , Kirsch JR , et al.   Neuroprotective kappaopioid receptor agonist BRL 52537 attenuates ischemiaevoked nitric oxide production in vivo in rats . Stroke . 2003;34:1533–1538
  27. Hjelmstad GO , Fields HL . Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms . J Neurophysiol . 2003;89:2389–2395
  28. Green AR , Hainsworth AH , Jackson DM . GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke . Neuropharmacology . 2000;39:1483–1494
  29. Schwartz-Bloom RD , Sah R . Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia . J Neurochem . 2001;77:353–371
  30. Globus MY , Busto R , Martinez E , et al.   Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat . J Neurochem . 1991;57:470–478
  31. Inglefield JR , Perry JM , Schwartz RD . Postischemic in hibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus . Hippocampus . 1995;5:460–468
  32. Phillis JW , Smith-Barbour M , Perkins LM , O'Regan MH . Characterization of glutamate, aspartate, and GABA release from ischemic rat cerebral cortex . Brain Res Bull . 1994;34:457–466
  33. Schwartz RD , Yu X , Katzman MR , et al.   Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum . J Neurosci . 1995;15:529–539
  34. Shuaib A , Ijaz S , Miyashita H , et al.   Progressive decrease in extracellular GABA concentrations in the post-ischemic period in the striatum: a microdialysis study . Brain Res . 1994;666:99–103

PII: S1016-3190(08)60051-8

doi: 10.1016/S1016-3190(08)60051-8

Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 280-285 , December 2008

Article Tools